Novartis Confident About Further Growth For 'Big Two'
New Indications On Track For Cosentyx And Entresto
As well as highlighting Novartis's burgeoning pipeline, the Swiss major's CEO is confident that its biggest earners will continue to growth for the next five years at least.
